Cyclin and cyclin-dependent kinase expression in human astrocytoma cell lines

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 3, 1997, Pages 291-300

  Dirks, Peter B ^a   Hubbard, Sherri Lynn ^a   Murakami, Masaji ^a   Rutka, James T ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Cyclin dependent kinases; Cyclins; Malignant astrocytoma; Tumor biology

Indexed keywords

CYCLIN A; CYCLIN B; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; CYCLINE; MESSENGER RNA;

ARTICLE; ASTROCYTOMA; CANCER CELL CULTURE; CELL PROLIFERATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RNA ANALYSIS;

EID: 0030728496     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199703000-00008     Document Type: Article

References (49)

1. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994;266:1821-28
2. Hunter T, Pines J. Cyclins and cancer II. Cyclin D and CDK inhibitors come of age. Cell 1994;79:573-78
3. Zhang H, Hannon GJ, Beach D. p21 containing cyclin kinases exist in both active and inactive states. Genes Dev 1994;8:1750-58
4. Harper JW, Elledge SJ, Keyomarsi K, et al. Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 1995;6:387-400
5. He J, Allen JR, Collins VP, et al. CDK4 amplification is an alternative mechanism to p16 homozygous deletion in glioma cell lines. Cancer Res 1994;54:5804-7
6. INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene. Oncogene 1996;13:1065-72
7. Jen JJ, Harper JW, Bigner S, et al. Deletion of p16 and p 15 in brain tumors. Cancer Res 1995;54:6353-58
8. Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in the genesis of many tumor types. Science 1994;264:436-40
9. INK4 expression is frequent in high grade gliomas. Cancer Res 1995;55:1941-45
10. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994;368:753-56
11. Saxena A, Robertson JT, Ali IU. Abnormalities of p16, p15 and CDK4 genes in recurrent malignant astrocytomas. Oncogene 1996;13:661-64
12. Schmidt EE, Ichimura K, Reifenberger G, Collins VP. CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 1994;54:6321-24
13. Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Research 1996;56:150-53
14. Walker DG, Duan W, Popovic EA, Kaye AA, Tomlinson FH, Lavin M. Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytoma. Cancer Res 1995;55:20-23
15. Leach FS, Elledge SJ, Sherr CJ, et al. Amplification of cyclin genes in colorectal carcinomas. Cancer Res 1993;53:1986-89
16. Keyomarsi K, Pardee AB. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 1993;90:1112-16
17. Keyomarsi K, O'Leary N, Molnar G, et al. Cyclin E, a potential prognostic marker for breast carcinoma. Cancer Res 1994;54:380-85
18. Buckley MF, Sweeney KJ, Hamilton JA, et al. Expression and am plification of cyclin genes in human cancer. Cancer Res 1993;8: 2127-33
19. Wang J, Chenivesse X, Henglein B, Brechot C. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature 1990;343:555-57
20. Gong J, Ardelt B, Tragnos F, Darzynkiewicz Z. Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumor cell lines. Cancer Res 1994;54:4285-88
21. Rutka JT, Giblin JR, Dougherty DV, et al. Establishment and characterization of five cell lines derived from human malignant gliomas. Acta Neuropathol 1987;75:92-103
22. Rutka JT, Giblin JR, Hoifodt HK, et al. Establishment and characterization of a cell line from a human gliosarcoma. Cancer Res 1986;46:5893-5902
23. Keyomarsi K, Sandoval L, Band V, Pardee AB. Synchronization of tumor cells and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res 1992;51:3602-9
24. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-85
25. Reifenberger G, Reifenberger J, Ichimura K, Meltzer PS, Collins VP. Amplification of multiple genes from chromosomal region 12q13 in human malignant gliomas: Preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, MDM2. Cancer Res 1994;54:4299-4303
26. Giani C, Finocchiaro G. Mutation rate of CDKN2 gene in malignant glioma. Cancer Res 1994;54:6338-39
27. Dreyling MH, Bohlander SK, Adeyanju MO, Olopade, OI. Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization. Cancer Res 1995;55:984-88
28. Moulton T, Samara G, Chung WY, et al. MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme. Am J Pathol 1995;146:613-19
29. Petronio J, He J, Fults D, Pedoni C, James CD, Allen JR. Common alternative gene alterations in adult malignant astrocytomas, but not in childhood primitive neuroectodermal tumors: p16INK4 homozygous deletions and CDK4 gene amplifications. J Neurosurg 1996;84:1020-23
30. Xiong Y, Connolly T, Futcher B, Beach D. Human D-type cyclin. Cell 1991;65:691-99
31. Arap W, Nishikawa R, Furnari F, Cavanee WK, Huang HJ. Replacement of the p16/CDKN2 gene suppresses human glioma cell growth. Cancer Res 1995;55:1351-55
32. INK4 gene in human glioma cells. Oncogene 1996;12: 2029-34
33. Guan KL, Jenkins CW, Li Y, et al. Growth suppression by p18, a p16INK4/MTS1 and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRB function. Genes Dev 1994;8:2939-52
34. Chan FK, Zhang J, Cheng L, Shapiro D, Winoto A. Identification of mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16INK4. Mol Cell Biol 1995;15:2682-88
35. Hirai H, Roussel MF, Kato JY, Ashmun RA, Sherr CJ. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol Cell Biol 1995;15: 2672-81
36. Van Meir EG, Kikuchi T, Tada M, et al. Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res 1994;54:649-52
37. Huppi K, Siwarski D, Dosik J, et al. Molecular cloning, sequencing, chromosomal location and expression of mouse p21. Oncogene 1994;9:3017-20
38. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D. Induction of WAF1/CIP1 by a p53 independent pathway. Cancer Res 1994;54:3391-95
39. Sheikh MS, Li XS, Chen JC, Shao ZM, Ordonez JV, Fontana JA. Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: Role of p53-dependent and p53 independent signal transduction pathways. Oncogene 1994;9:3407-15
40. Bhatia K, Fan S, Spangler G, et al. A mutant p21 cyclin dependent kinase inhibitor isolated from a Burkitt's lymphoma. Cancer Res 1995;55:1431-35
41. Li YJ, Laurent-Puig P, Salmon RJ, Thomas G, Hamelin R. Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer. Oncogene 1995;10:599-601
42. Shiohara M, El-Deiry WS, Wada M, et al. Absence of WAF1 mutations in a variety of human malignancies. Blood 1994;84:3781-84
43. Kip1, to regions involved in human cancer. Cancer Res 1995;55:1199-1205
44. Kawamata N, Morosetti R, Miller CW, et al. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res 1995;55:2266-69
45. Kip1: Chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res 1995;55:1211-14
46. Bartkova J, Lukas J, Muller H, Strauss M, Gusterson B, Bartek, J. Abnormal patterns of cyclin expression and G1 regulation in human head and neck cancer. Cancer Res 1995;55:949-56
47. Gillett C, Fantl V, Smith R, et al. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994;54:1812-17
48. Zhang SY, Caamano J, Cooper F, Guo X, Klein-Szanto AJ. Immunohistochemistry of cyclin D1 in human breast cancer. Am J Clin Pathol 1994;102:695-98
49. Bartkova J, Lukas J, Strauss M, Bartek J. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histiogenesis. Oncogene 1995;10:775-78